CIAM
LEGN icon

Caitong International Asset Management’s Legend Biotech LEGN Stock Holding History

Caitong International Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,681
Closed -$30.4K – 3258
2026
Q1 		$30.4K Sell
1,681
-1,888
-53% -$36K 0.01% 918
2025
Q4 		$77.6K Buy
3,569
+3,374
+1,730% +$96.6K 0.02% 540
2025
Q3 		$6.36K Buy
+195
New +$7.2K ﹤0.01% 1158
2025
Q2 		– Sell
-667
Closed -$22.6K – 2251
2025
Q1 		$22.6K Sell
667
-303
-31% -$10.9K 0.02% 717
2024
Q4 		$31.6K Buy
+970
New +$40.2K 0.03% 646

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Caitong International Asset Management's LEGN Position: Q2 2026 in Review

Caitong International Asset Management sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 1,681 shares — an estimated $30.4K sold.

Caitong International Asset Management first reported a position in LEGN in Q4 2024 and held it in 5 quarters. The position peaked at $77.6K in Q4 2025. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Caitong International Asset Management reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 1,681 Legend Biotech shares in Q2 2026, an estimated $30.4K.
  • Caitong International Asset Management first reported a position in Legend Biotech in Q4 2024 and held it in 5 quarters.
  • Caitong International Asset Management's Legend Biotech position peaked at $77.6K in Q4 2025.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.